Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Other Accumulated Expenses (2023 - 2025)

INVO Fertility (IVF) has disclosed Other Accumulated Expenses for 3 consecutive years, with $10500.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 97.0% to $10500.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $10500.0, a 97.0% decrease, with the full-year FY2024 number at $410000.0, up 17.14% from a year prior.
  • Other Accumulated Expenses was $10500.0 for Q3 2025 at INVO Fertility, roughly flat from $10500.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $715245.0 in Q1 2025 to a low of $10500.0 in Q2 2025.
  • A 3-year average of $296630.8 and a median of $350000.0 in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: surged 183.56% in 2024, then plummeted 97.0% in 2025.
  • INVO Fertility's Other Accumulated Expenses stood at $350000.0 in 2023, then rose by 17.14% to $410000.0 in 2024, then crashed by 97.44% to $10500.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Other Accumulated Expenses are $10500.0 (Q3 2025), $10500.0 (Q2 2025), and $715245.0 (Q1 2025).